These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6670253)

  • 1. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
    Garmashova LM; Polezhaev FI; Aleksandrova GI
    Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
    Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
    Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57].
    Aleksandrova GI; Medvedeva TE; Polezhaev FI; Garmashova LM; Budilovskiĭ GN
    Vopr Virusol; 1986; 31(4):411-4. PubMed ID: 2945324
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees.
    Alexandrova GI; Polezhaev FI; Budilovsky GN; Garmashova LM; Topuria NA; Egorov AY; Romejko-Gurko YR; Koval TA; Lisovskaya KV; Klimov AI
    Infect Immun; 1984 Jun; 44(3):734-9. PubMed ID: 6724695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
    Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
    Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
    Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics].
    Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI
    Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].
    Markushin SG; Tsfasman TM; Terekhov AV; Lisovskaya KV; Akopova II
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):27-32. PubMed ID: 26829850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children.
    Klimov AI; Egorov AY; Gushchina MI; Medvedeva TE; Gamble WC; Rudenko LG; Alexandrova GI; Cox NJ
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1521-5. PubMed ID: 7782782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome].
    Egorov AIu; Garmashova LM; Nevedomskaia GN; Bogomolova LI; Khaĭder AM; Aleksandrova GI
    Vopr Virusol; 1994; 39(5):198-201. PubMed ID: 7716900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice.
    Wareing MD; Watson JM; Brooks MJ; Tannock GA
    J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses].
    Rekstin AR; Lu K; Kats D; Rudenko LG
    Vopr Virusol; 2006; 51(2):27-30. PubMed ID: 16756175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.